Biotech

All Articles

Bicara, Zenas find IPOs to press late-phase assets towards market

.Bicara Therapies as well as Zenas Biopharma have provided fresh catalyst to the IPO market along wi...

Genentech to shut cancer immunology analysis department

.Genentech will close its cancer immunology analysis team, as well as system mind and also prominent...

Kezar falls solid tumor yet to prove its own truly worth in phase 1 trial

.Kezar Life Sciences is falling its own unpromising phase 1 solid cyst drug as the biotech goes all-...

Acelyrin drops izokibep, lays off 3rd of staff

.Regardless of izokibep sustaining its newfound winning touch in the medical clinic, Acelyrin is act...

Rivus' stage 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has plumped up the leads of its own fat-busting, muscle-sparing drug applican...

Ovid stops preclinical work, IV system after soticlestat fail

.Ovid Therapy presently revealed final month that it was actually trimming back its own head count a...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston ma Seaport, improving its...

Boundless Bio creates 'modest' cutbacks 5 months after $100M IPO

.Only five months after getting a $100 thousand IPO, Limitless Bio is actually already laying off so...

Halda's $126M will certainly advance 'hold and also eliminate' tumor medicines

.The first stages of oncology R&ampD may not be short of fascinating brand-new techniques, as well a...

Lykos 'disappointments' certainly not divulging research study transgressions along with publisher

.Psychopharmacology has taken 3 posts regarding midstage scientific test information evaluating Lyko...